Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Evelo Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 62 | 1 | 66 | +5 |
| Shares | 47.5M | 32.5K | 47.0M | −474.0K (−1.0%) |
| Value | $508.0M | $347.0K | $645.4M | +$137.7M (+27.1%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alberta Investment Management Corp | 40,000 | $550.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 33,774 | $464.0K | 0.00% |
| Amundi | 32,472 | $446.0K | 0.00% |
| AE Wealth Management LLC | 14,087 | $194.0K | 0.00% |
| Virtus ETF Advisers LLC | 13,690 | $188.0K | 0.08% |
| Voya Investment Management LLC | 12,125 | $167.0K | 0.00% |
| MetLife Investment Management | 12,153 | $167.0K | 0.00% |
| Old Mission Capital LLC | 10,061 | $138.0K | 0.00% |
| Cresset Asset Management, LLC | 10,000 | $137.0K | 0.00% |
| Metropolitan Life Insurance Co | 8,937 | $122.8K | 0.00% |
| Acadian Asset Management LLC | 1,550 | $21.0K | 0.00% |
| US Bancorp | 271 | $4.00K | 0.00% |
| Lloyd Advisory Services, LLC. | 21 | $0 | 0.00% |
Sold out (8)
Institutions that held Evelo Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Avidity Partners Management LP | 800,000 | $8.56M |
| Invesco Ltd. | 164,459 | $1.76M |
| Caas Capital Management LP | 82,498 | $883.0K |
| Federated Hermes, Inc. | 70,448 | $754.0K |
| Susquehanna International Group, LLP | 34,473 | $369.0K |
| Canada Pension Plan Investment Board | 25,000 | $268.0K |
| Jane Street Group, LLC | 12,487 | $134.0K |
| Bank of Montreal | 2,388 | $24.0K |
Not filed for Q2 2021 yet (1)
Institutions that held Evelo Biosciences, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Amundi Asset Management US, Inc. | 32,472 | $347.0K |